Latest Market Research Reports

  Drug Discovery Outsourcing Market Summary The global  drug discovery outsourcing market  size was estimated at USD 7.44 billion in 2024 and is projected to reach USD 17.11 billion by 2033, growing at a CAGR of 9.83% from 2025 to 2033. The strong market trajectory is attributed to several key drivers, including increasing complexity of diseases worldwide, the rising necessity for innovative treatment options, and the growing demand for novel modalities such as biologics and gene therapies. Additionally, the adoption of advanced research tools and technologies like artificial intelligence, in silico modeling, and high-throughput screening supports the development of efficient and targeted drug discovery solutions. The market rapidly expands as pharmaceutical companies seek to improve innovation efficiency, lower operational risks, and reduce time-to-market for new therapies. Furthermore, emerging biopharmaceutical companies heavily rely on outsourcing partners due to the ...

  Drug Discovery Outsourcing Industry The global  drug discovery outsourcing market  size is expected to reach USD 10.23 billion by 2030 and is expected to expand at a CAGR of 7.58% from 2025 to 2030, according to a new report by Grand View Research, Inc., The COVID-19 pandemic has brought pharmaceutical companies in limelight. Drug discovery is a costly and lengthy process. This has urged pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Rising partnerships between public or private entities accelerate drug discovery processes, which, in turn, increase the global demand for outsourcing services for drug discovery. This scenario is expected to sustain post-Covid implications as well. A rise in cases of chronic diseases has urged companies to develop medicines that extend life expectancy. According to the United Nations, people aged 65 years between 2015 and 2020 are expecte...